Standard Biotools (LAB) Depreciation & Amortization (CF) (2010 - 2026)

Standard Biotools (LAB) has 17 years of Depreciation & Amortization (CF) data on file, last reported at $1.4 million in Q1 2026.

• Depreciation & Amortization (CF) for Q1 2026 came in at $1.4 million, down 56.98% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.4 million (down 41.76% YoY), and the FY2025 annual result was $9.3 million, down 25.99% from the prior year.
• Depreciation & Amortization (CF) rose to $1.4 million in Q1 2026 per LAB's latest filing, from $1.3 million in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $3.3 million in Q1 2025 and troughed at $802000.0 in Q3 2022.
• A 5-year average of $1.8 million and a median of $1.3 million in 2025 frame the typical range for Depreciation & Amortization (CF).
• The sharpest annual moves came in 2022 and 2024: Depreciation & Amortization (CF) tumbled 91.03% in 2022, then surged 280.15% in 2024.
• A 5-year view of Depreciation & Amortization (CF) shows it stood at $819000.0 in 2022, then surged by 35.04% to $1.1 million in 2023, then surged by 183.91% to $3.1 million in 2024, then plunged by 58.89% to $1.3 million in 2025, then advanced by 9.06% to $1.4 million in 2026.
• Business Quant data shows LAB's Depreciation & Amortization (CF) at $1.4 million in Q1 2026, $1.3 million in Q4 2025, and $1.5 million in Q3 2025.